Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedservRegisMAL:MDS 42 Net Margin % is 3.76% as of Dec. 2025. GuruFocus rates MAL:MDS with a GF Score™ of 42/100 and a GF Value™ of €0.92 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 916 Oil & Gas companies, MedservRegis ranks better than 55.02% on this metric.
Net margin is calculated as Net Income divided by its Revenue. MedservRegis's Net Income for the
six
months ended in Dec. 2025 was €2.3 Mil. MedservRegis's Revenue for the
six
months ended in Dec. 2025 was €59.9 Mil. Therefore, MedservRegis's net margin for the quarter that ended in Dec. 2025 was 3.76%.
The historical rank and industry rank for MedservRegis's Net Margin % or its related term are showing as below:
MAL:MDS'
s Net Margin % Range Over the Past 10 Years
Min: -112.31 Med: -1.7 Max: 9.56
Current: 4.96
MAL:MDS's Net Margin % is ranked better than 55.02% of 916
companies
in the Oil & Gas industry
Industry Median: 3.48
vs MAL:MDS: 4.96
MedservRegis (MAL:MDS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
MedservRegis Net Margin % Related Terms
MedservRegis Net Margin % Historical Data
* Premium members only.
The historical data trend for MedservRegis's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Oil & Gas Equipment & Services subindustry, MedservRegis's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedservRegis Net Margin % vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, MedservRegis's Net Margin % distribution charts can be found below:
* The bar in red indicates where MedservRegis's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedservRegis (MAL:MDS) has a Net Margin % of 3.76% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on MedservRegis and its competitors. According to the industry distribution chart, MedservRegis ranks #412 out of 916 companies in the Oil & Gas industry, placing it in the top 45%.
Is MedservRegis' Net Margin % too high?
MedservRegis' current Net Margin % is 3.76%. The Oil & Gas industry median Net Margin % is 3.48. MedservRegis' value of 3.76% is 8% above this industry median. Based on the distribution chart, MedservRegis ranks #412 out of 916 companies in the Oil & Gas industry, which is above the industry midpoint. Overall, MedservRegis has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MedservRegis' Net Margin % compare to SLB and BKR?
According to the Oil & Gas industry distribution chart, MedservRegis ranks #412 out of 916 companies for Net Margin %. This puts MedservRegis in the upper half of its industry. The industry median Net Margin % is 3.48. MedservRegis' value of 3.76% is 8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for an Oil & Gas company?
The median Net Margin % among Oil & Gas companies is 3.48, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedservRegis's current Net Margin % of 3.76% is 8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on MedservRegis and its competitors. For the Oil & Gas industry, the median Net Margin % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedservRegis's current Net Margin % is 3.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedservRegis stock overvalued right now?
Based on GuruFocus' analysis, MedservRegis (MAL:MDS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.92, compared to a current price of €0.69 — trading 25% below its estimated fair value. The current Net Margin % is 3.76% and 8% above the Oil & Gas industry median of 3.48. MedservRegis' overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For MedservRegis (MAL:MDS), the current Net Margin % is 3.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedservRegis (MAL:MDS) Overvalued in 2026?
Based on GuruFocus' analysis, MedservRegis stock appears to be undervalued.
The current stock price of €0.69 is trading 25% below its estimated GF Value™ of €0.92.
GuruFocus considers MedservRegis to be Modestly Undervalued.
Key valuation signals for MAL:MDS:
Net Margin %: 3.76%
GF Value™: €0.92 vs. price of €0.69 (25% below fair value)
Industry Position: 8% above the Oil & Gas median (#412 of 916)
No single metric tells the full story. See the MAL:MDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedservRegis PLC is engaged in providing shore-based logistics to the offshore oil and gas industry and engineering and supply chain management for oil country tubular goods (OCTG) to support the onshore oil and gas industry. Its segment includes Integrated logistics support services; Oil country tubular goods; Trading activity and Photovoltaic farms. The company generates maximum revenue from the Integrated logistics support services segment, that Includes the provision of comprehensive logistical support services to the offshore oil and gas industry from the group's bases in Malta, Cyprus, Egypt, South America, and Africa.
42GF Score
Get the complete analysis for MAL:MDS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAL:MDS has been successfully added to your 
